Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic methylergonovine plus oxytocin vs oxytocin alone for prevention of postpartum hemorrhage after twin cesarean
IRCT20250509065661N1Phase 3Completed
- Sponsor
- Vice-Chancellor for Research of Qazvin University of Medical Sciences
- Start
- Jun 2025
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in postpartum hemorrhage (PPH) and Twin Pregnancy comparing Methylergonovine plus oxytocin prophylaxis with Oxytocin alone prophylaxis (2 arms). Started Jun 2025; status: completed.
02
Drugs
methylergometrineoxytocin
03
Conditions
postpartum hemorrhage (PPH)Twin Pregnancy
Beyond the preview
Go deeper on IRCT20250509065661N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250509065661N1.